Abstract
90O - The role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have